SCHEMBL7014564

SCHEMBL7014564

Nc1cc(-n2cc(C(=O)O)c(=O)c3c(O)c(F)c(N4CC(N)C4)c(F)c32)c(F)cc1F

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
TOP2A P11388 12/20 0.43
TOP2B Q02880 8/20 0.43
TOP1 P11387 4/20 0.43
STAT3 P40763 1/20 0.42
CACNA1F O60840 1/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.42
CACNA1D Q01668 1/20 0.42
KCNH2 Q12809 1/20 0.42
CACNA1S Q13698 1/20 0.42
CACNA1C Q13936 1/20 0.42
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7010194 0.91 CACNA1F (0.51) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL6576258 0.87 CYP3A4 (0.46) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL7008959 0.85 CYP3A4 (0.58) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL7011332 0.84 TOP2A (0.53) TOP2ATOP2BTOP1CACNA1FPOLB
SCHEMBL8478277 0.84 TOP2A (0.53) TOP2ATOP2BTOP1CACNA1FPOLB
SCHEMBL7008071 0.84 CYP3A4 (0.41) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL7007135 0.84 STAT3 (0.54) TOP2ATOP2BTOP1STAT3POLB
SCHEMBL7005373 0.83 CYP3A4 (0.53) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL7012569 0.82 CYP3A4 (0.56) CYP3A4CYP2C9TOP2ATOP2BTOP1
SCHEMBL6580734 0.81 CYP3A4 (0.56) CYP3A4CYP2C9TOP2ATOP2BTOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0787720-B1 PYRIDONECARBOXYLATE DERIVATIVE OR SALT THEREOF AND ANTIBACTERIAL CONTAINING THE SAME AS ACTIVE INGREDIENT WAKUNAGA SEIYAKU KK (JP) 2003-07-16 EP disclosed
US-5910498-A NOVEL COMPOUNDS HAVING REDUCED CYTOTOXICITY, PHOTOTOXICITY; TREATING BACTERIAL AND VIRAL INFECTIONS WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1999-06-08 US disclosed